Coronavirus NASA News

Metagenomic Sequencing Market Dynamics, Therapeutics and forecast to 2023

Market Analysis 

 

This method along with offering species identification, classification, as well as quantitation of microbes, will also at the same time offer information for functional analysis of genes with the help of metabolic pathway analysis and gene ontology. Its key benefit is that metagenomics allows the study and discovery of microbial genomes that otherwise would be intractable owing to cultivation difficulties.

 

The global Metagenomic Sequencing Industry  is predicted to grow at a 6.5% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Metagenomics, simply put, is a molecular tool that is used for analyzing DNA that is acquired from environmental samples to study the community of microorganisms present in their natural habitat devoid of the need to obtain pure cultures.

 

Get a Free Sample @  https://www.marketresearchfuture.com/sample_request/5598

 

Various factors are propelling the metagenomic sequencing market growth. These factors, as stated by the latest MRFR report, include growing awareness about genetic disorders, improved genomic tools, advanced technological platforms, funding and favorable initiatives undertaken by private bodies and government for large-scale sequencing projects, declining cost of sequencing, and recovery of new drugs. Additional factors propelling market growth include high throughput screening methods, development of cost-effective technologies (next-generation sequencing), increasing research and development for identifying new enzymes and antibiotics, and improved bioinformatics.

 

Key Players:

 

include Knome Inc. (US), Helicos BioSciences (US), Macrogen Inc. (South Korea), DNAStar Inc. (US), Agilent Technologies Inc. (US), CLC Bio (Qiagen) (Denmark), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (US), Biomatters Ltd. (New Zealand), Beijing Genomics Institute (China), Pacific Biosciences (US), COSMOSID (US), GenapSys, Inc. (US), Freenome Inc. (US), Quest Diagnostics Incorporated (US), Second Genome Therapeutics (US), SciGenom Labs Pvt. Ltd. (India), F Hoffman-La Roche Ltd. (Switzerland), The Mitre Corporation (US), Aperiomics, Inc. (US), Illumina Inc. (US), Enterome Bioscience (France), and Biotech AG (Germany). 

 

Market Segmentation :

 

  • The MRFR report provides a complete segmental analysis of the Metagenomic Sequencing Market report on the basis of end user, application, and technology.

 

  • Based on technology, the metagenomic sequencing market is segmented into bioinformatics, sequencing, and others.

 

  • Based on application, the metagenomic sequencing market is segmented into agriculture, ecology, biofuel, biotechnology, gut microbe characterization, environmental remediation, and infectious disease diagnosis.

 

  • Based on end user, the metagenomic sequencing market is segmented into specialized clinics, research institutes, hospitals, and others.

 

Regional Analysis:

 

By region, the metagenomic sequencing market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. Factors aiding growth in the region include advancements in technology in the next-generation sequencing methods and its increasing applications.

 

The metagenomic sequencing market in Europe is predicted to have the second-largest share in the market over the forecast period. Factors aiding growth in the region include increasing investment by government and hospital facilities for better healthcare, increasing use of NGS techniques by research laboratories, low cost of sequencing, and growing partnerships and collaborations.

 

Access Full Report Details @ https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598

 

 

The metagenomic sequencing market in the APAC region is predicted to grow in the fastest pace over the forecast period. Factors aiding growth in the region include increasing incidence of genetic disorders worldwide, and affordable healthcare & research.

 

Related Reports:

 

Cell Therapy Market Research Report- Global Forecast till 2023

https://www.marketresearchfuture.com/infographics/cell-therapy-market

 

Carotid Artery Disease Market Research Report – Global Forecast till 2023

https://www.marketresearchfuture.com/infographics/carotid-artery-disease-market

 

Related Videos:

Veterinary Imaging Market Insights 2019-2023

https://www.marketresearchfuture.com/videos/veterinary-imaging-market